APA (7th ed.) Citation

Holodniy, M., & Kaiser, J. D. (2019). Treatment for Gulf War Illness (GWI) with KPAX002 (methylphenidate hydrochloride + GWI nutrient formula) in subjects meeting the Kansas case definition: A prospective, open-label trial. Journal of psychiatric research, 118, 14-20. https://doi.org/10.1016/j.jpsychires.2019.08.003

Chicago Style (17th ed.) Citation

Holodniy, Mark, and Jon D. Kaiser. "Treatment for Gulf War Illness (GWI) with KPAX002 (methylphenidate Hydrochloride + GWI Nutrient Formula) in Subjects Meeting the Kansas Case Definition: A Prospective, Open-label Trial." Journal of Psychiatric Research 118 (2019): 14-20. https://doi.org/10.1016/j.jpsychires.2019.08.003.

MLA (9th ed.) Citation

Holodniy, Mark, and Jon D. Kaiser. "Treatment for Gulf War Illness (GWI) with KPAX002 (methylphenidate Hydrochloride + GWI Nutrient Formula) in Subjects Meeting the Kansas Case Definition: A Prospective, Open-label Trial." Journal of Psychiatric Research, vol. 118, 2019, pp. 14-20, https://doi.org/10.1016/j.jpsychires.2019.08.003.